These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32781240)

  • 1. Group 2 innate lymphoid cells in nasal polyposis.
    Stevens WW; Kato A
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):110-117. PubMed ID: 32781240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps.
    Ogasawara N; Poposki JA; Klingler AI; Tan BK; Hulse KE; Stevens WW; Peters AT; Grammer LC; Welch KC; Smith SS; Conley DB; Raviv JR; Soroosh P; Takano KI; Himi T; Kern RC; Schleimer RP; Kato A
    Mucosal Immunol; 2020 Jan; 13(1):86-95. PubMed ID: 31641233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis.
    Miljkovic D; Bassiouni A; Cooksley C; Ou J; Hauben E; Wormald PJ; Vreugde S
    Allergy; 2014 Sep; 69(9):1154-61. PubMed ID: 24924975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps.
    Poposki JA; Klingler AI; Tan BK; Soroosh P; Banie H; Lewis G; Hulse KE; Stevens WW; Peters AT; Grammer LC; Schleimer RP; Welch KC; Smith SS; Conley DB; Raviv JR; Karras JG; Akbari O; Kern RC; Kato A
    Immun Inflamm Dis; 2017 Sep; 5(3):233-243. PubMed ID: 28474861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
    Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
    Clin Exp Allergy; 2015 Feb; 45(2):394-403. PubMed ID: 25429730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group 2 innate lymphoid cells and eosinophilic chronic rhinosinusitis.
    Tojima I; Shimizu T
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):18-25. PubMed ID: 30507713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps.
    Lee M; Kim DW; Shin HW
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):17-22. PubMed ID: 27870664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proallergic cytokines and group 2 innate lymphoid cells in allergic nasal diseases.
    Matsushita K; Kato Y; Akasaki S; Yoshimoto T
    Allergol Int; 2015 Jul; 64(3):235-40. PubMed ID: 26117254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis.
    Tojima I; Kouzaki H; Shimizu S; Ogawa T; Arikata M; Kita H; Shimizu T
    Clin Immunol; 2016 Sep; 170():1-8. PubMed ID: 27422491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathology of chronic rhinosinusitis.
    Kato A
    Allergol Int; 2015 Apr; 64(2):121-30. PubMed ID: 25838086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local immunoglobulin production in nasal tissues: A key to pathogenesis in chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease.
    Buchheit KM; Hulse KE
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):127-134. PubMed ID: 33065294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
    Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
    J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs.
    Bal SM; Bernink JH; Nagasawa M; Groot J; Shikhagaie MM; Golebski K; van Drunen CM; Lutter R; Jonkers RE; Hombrink P; Bruchard M; Villaudy J; Munneke JM; Fokkens W; Erjefält JS; Spits H; Ros XR
    Nat Immunol; 2016 Jun; 17(6):636-45. PubMed ID: 27111145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type 2 innate lymphoid cells and chronic rhinosinusitis].
    Geng CL; Xing ZM
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):585-588. PubMed ID: 29871081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.
    Stevens WW; Ocampo CJ; Berdnikovs S; Sakashita M; Mahdavinia M; Suh L; Takabayashi T; Norton JE; Hulse KE; Conley DB; Chandra RK; Tan BK; Peters AT; Grammer LC; Kato A; Harris KE; Carter RG; Fujieda S; Kern RC; Schleimer RP
    Am J Respir Crit Care Med; 2015 Sep; 192(6):682-94. PubMed ID: 26067893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crocin Inhibits the Type 2 Inflammatory Response Produced by ILC2s in Eosinophilic Nasal Polyps.
    Xiaodong X; Tao L; Jianmin L; Jing Z; Bing Z; Jintao D; Bachert C; Luo B
    Am J Rhinol Allergy; 2023 Nov; 37(6):656-669. PubMed ID: 37424236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory heterogeneity in aspirin-exacerbated respiratory disease.
    Scott WC; Cahill KN; Milne GL; Li P; Sheng Q; Huang LC; Dennis S; Snyder J; Bauer AM; Chandra RK; Chowdhury NI; Turner JH
    J Allergy Clin Immunol; 2021 Apr; 147(4):1318-1328.e5. PubMed ID: 33189729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspergillus fumigatus induction of IL-33 expression in chronic rhinosinusitis is PAR2-dependent.
    Dietz CJ; Sun H; Yao WC; Citardi MJ; Corry DB; Luong AU
    Laryngoscope; 2019 Oct; 129(10):2230-2235. PubMed ID: 30973971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target.
    Jin J; Sunusi S; Lu H
    J Int Med Res; 2022 Jan; 50(1):3000605211053156. PubMed ID: 35048721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tc17/IL-17A Up-Regulated the Expression of MMP-9 via NF-κB Pathway in Nasal Epithelial Cells of Patients With Chronic Rhinosinusitis.
    Chen X; Chang L; Li X; Huang J; Yang L; Lai X; Huang Z; Wang Z; Wu X; Zhao J; Bellanti JA; Zheng SG; Zhang G
    Front Immunol; 2018; 9():2121. PubMed ID: 30283454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.